177 related articles for article (PubMed ID: 7818279)
1. Platelet activating factor (PAF) and lyso-PAF in psoriasis.
Judge MR; Barr RM; Mallet AI; Courtney F; Kobza Black A; Greaves MW
Arch Dermatol Res; 1994; 286(7):376-9. PubMed ID: 7818279
[TBL] [Abstract][Full Text] [Related]
2. Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.
Barr RM; Lawlor F; Judge MR; Courtney P; Barlow R; Kobza Black A; Mallet AI; Greaves MW
Br J Clin Pharmacol; 1993 Jun; 35(6):637-41. PubMed ID: 8329291
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor and human thyroid cancer.
Denizot Y; Chianéa T; Labrousse F; Truffinet V; Delage M; Mathonnet M
Eur J Endocrinol; 2005 Jul; 153(1):31-40. PubMed ID: 15994743
[TBL] [Abstract][Full Text] [Related]
4. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
[TBL] [Abstract][Full Text] [Related]
5. The lyso-precursor of platelet-activating factor (lyso-PAF) in ischaemic myocardium.
Leong L; Sturm M; Taylor R
J Lipid Mediat; 1991 Nov; 4(3):277-87. PubMed ID: 1764576
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation.
Izaki S; Yamamoto T; Goto Y; Ishimaru S; Yudate F; Kitamura K; Matsuzaki M
Br J Dermatol; 1996 Jun; 134(6):1060-4. PubMed ID: 8763425
[TBL] [Abstract][Full Text] [Related]
7. Presence and metabolism of lyso platelet-activating factor in human bone marrow.
Denizot Y; Rougier F; Dupuis F; Trimoreau F; Dulery C; Laskar M; Praloran V
J Lipid Mediat Cell Signal; 1997 May; 16(1):53-62. PubMed ID: 9101422
[TBL] [Abstract][Full Text] [Related]
8. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
[TBL] [Abstract][Full Text] [Related]
9. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery.
Stephens CJ; Graham RM; Yadava OP; Leong LL; Sturm MJ; Taylor RR
Cardiovasc Res; 1992 Jan; 26(1):25-31. PubMed ID: 1516109
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF.
Flamand N; Lefebvre J; Lapointe G; Picard S; Lemieux L; Bourgoin SG; Borgeat P
J Leukoc Biol; 2006 May; 79(5):1043-51. PubMed ID: 16501051
[TBL] [Abstract][Full Text] [Related]
11. Activation of phospholipase A2 and acylation of lysophospholipids: the major regulators for platelet activating factor production in rat neutrophils.
Naraba H; Imai Y; Kudo I; Nakagawa Y; Oh-ishi S
J Biochem; 1995 Aug; 118(2):442-7. PubMed ID: 8543583
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of the lyso-derivative of platelet-activating factor are related to age.
Taylor RR; Sturm M; Kendrew PJ; Vandongen R; Beilin LJ
Clin Sci (Lond); 1989 Feb; 76(2):195-8. PubMed ID: 2924511
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue.
Andersen S; Sjursen W; Laegreid A; Volden G; Johansen B
Inflammation; 1994 Feb; 18(1):1-12. PubMed ID: 8206642
[TBL] [Abstract][Full Text] [Related]
14. Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients.
Denizot Y; Gainant A; Guglielmi L; Bouvier S; Cubertafond P; Mathonnet M
Oncogene; 2003 Oct; 22(46):7222-4. PubMed ID: 14562051
[TBL] [Abstract][Full Text] [Related]
15. Lyso-PAF, a biologically inactive phospholipid, contributes to RAF1 activation.
Gao X; Liu Y; Li Y; Fan H; Wu R; Zhang R; Faubert B; He YY; Bissonnette MB; Xia S; Chen D; Mao H; Boggon TJ; Chen J
Mol Cell; 2022 Jun; 82(11):1992-2005.e9. PubMed ID: 35417664
[TBL] [Abstract][Full Text] [Related]
16. Short term vitamin E supplementation has no effect on platelet function, plasma phospholipase A2 and lyso-PAF in male volunteers.
Silbert PL; Leong LL; Sturm MJ; Strophair J; Taylor RR
Clin Exp Pharmacol Physiol; 1990 Sep; 17(9):645-51. PubMed ID: 2279352
[TBL] [Abstract][Full Text] [Related]
17. Activities of enzymes involved in the metabolism of platelet-activating factor in neural cell cultures during proliferation and differentiation.
Francescangeli E; Lang D; Dreyfus H; Boila A; Freysz L; Goracci G
Neurochem Res; 1997 Oct; 22(10):1299-307. PubMed ID: 9342735
[TBL] [Abstract][Full Text] [Related]
18. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
Bhawan J; Bansal C; Whren K; Schwertschlag U;
J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676
[TBL] [Abstract][Full Text] [Related]
19. Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release.
Metz SA
Diabetes; 1986 Jul; 35(7):808-17. PubMed ID: 3087803
[TBL] [Abstract][Full Text] [Related]
20. Study on the metabolism of lyso-platelet activating factor (lyso-PAF) in human paranasal sinus mucosa. The cultured ciliated epithelium can convert lyso-PAF to PAF.
Inoue H; Ganbo T; Hisamatsu K; Ishida H
Life Sci; 1993; 52(21):PL227-32. PubMed ID: 8502110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
